ITGB6 ProTriTAC

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameITGB6 ProTriTAC
Drug Alias Nameintegrin beta-6 protease-activated trispecific T-cell engager prodrug (Harpoon Therapeutics)
ClassificationBiologics > T cell engagers
Mechanisms of ActionIntegrin beta-6 modulatorsT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3Integrin beta-6
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarpoon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesHarpoon Therapeutics Inc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A